PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

NICE recommends Novartis’ secukinumab for children with moderate to severe psoriasis

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Cosentyx® (secukinumab) as an option for treating moderate to severe plaque ps...
Continue Reading →
News

EMA fast-tracks Marinus Pharma’s rare epilepsy treatment

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment ...
Continue Reading →
News

ICR cancer drug NXP800 to enter Phase I trials

An investigational drug called NXP800, discovered at the Cancer Research UK Cancer Therapeutics Unit at London’s Institute of Cancer Research (ICR), is to enter Phas...
Continue Reading →
News

Phase III data for Jardiance shows improvement in HFpEF patients

Results from the EMPEROR-Preserved Phase III trial have shown that Jardiance (empagliflozin) demonstrated a 21% relative risk reduction of cardiovascular death or ho...
Continue Reading →
News

Roche withdraws US approval for Tecentriq in mTNBC

Roche has voluntarily withdrawn its US accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for the treatment of adults with unresectab...
Continue Reading →
News

Dupixent trial meets endpoints for childhood eczema

The Phase III trial for Sanofi/Regeneron's Dupixent (dupilumab) plus topical corticosteroids (TCS) for the treatment of moderate-to-severe atopic dermatitis (eczema)...
Continue Reading →
News

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination ...
Continue Reading →
News

EU nod for Bimzelx for moderate to severe plaque psoriasis

The European Commission (EC) has granted marketing authorisation for UCB’s Bimzelx (bimekizumab) for the treatment of moderate to severe plaque psoriasis in adults w...
Continue Reading →
News

Kuvan approved for pregnant women with PKU in UK

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending BioMarin's Kuvan (sapropterin) as an option for treating ph...
Continue Reading →
News

Merck partners with start-up for neurostimulator development

Merck has announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH – a B. Braun subsidiary and early-stage start-up company based in ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026